Salish Bioscience is an oncology diagnostics company that develops advanced liquid biopsies.
Salish Bioscience has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2022.
Salish Bioscience is headquartered in Seattle, United States.
Salish Bioscience is an oncology diagnostics company that develops advanced liquid biopsies.
Salish Bioscience is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Salish Bioscience — Funding & Investors." VCBacked, April 13, 2022, https://www.vcbacked.co/company/salish-bioscience. Accessed September 30, 2026.
VCBacked. (2022). Salish Bioscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/salish-bioscience
{{cite web |title=Salish Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/salish-bioscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated